Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 20 | 2023 | 40 | 3.470 |
Why?
|
| Anaphylaxis | 4 | 2023 | 11 | 1.720 |
Why?
|
| Immunity, Innate | 2 | 2015 | 54 | 0.730 |
Why?
|
| Asthma | 7 | 2023 | 152 | 0.720 |
Why?
|
| Epinephrine | 3 | 2023 | 29 | 0.670 |
Why?
|
| Sinusitis | 5 | 2018 | 138 | 0.570 |
Why?
|
| Child | 13 | 2023 | 1153 | 0.570 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2008 | 9 | 0.560 |
Why?
|
| Surveys and Questionnaires | 7 | 2023 | 1019 | 0.500 |
Why?
|
| Child Day Care Centers | 2 | 2006 | 5 | 0.480 |
Why?
|
| Caregivers | 3 | 2023 | 185 | 0.480 |
Why?
|
| Desensitization, Immunologic | 1 | 2015 | 4 | 0.470 |
Why?
|
| Rhinitis | 4 | 2018 | 124 | 0.460 |
Why?
|
| Rhinitis, Allergic | 3 | 2023 | 14 | 0.460 |
Why?
|
| Renal Dialysis | 1 | 2015 | 82 | 0.440 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 120 | 0.420 |
Why?
|
| Humans | 34 | 2023 | 22823 | 0.410 |
Why?
|
| Dermatitis, Atopic | 3 | 2018 | 10 | 0.350 |
Why?
|
| Mast Cells | 2 | 2008 | 18 | 0.350 |
Why?
|
| Allergens | 4 | 2023 | 16 | 0.340 |
Why?
|
| Adolescent | 7 | 2023 | 1874 | 0.300 |
Why?
|
| Gastroesophageal Reflux | 2 | 2021 | 27 | 0.300 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 146 | 0.270 |
Why?
|
| Child, Preschool | 7 | 2021 | 563 | 0.270 |
Why?
|
| Hypersensitivity | 1 | 2008 | 38 | 0.270 |
Why?
|
| Female | 19 | 2022 | 12904 | 0.260 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2018 | 124 | 0.250 |
Why?
|
| Infant | 6 | 2021 | 478 | 0.230 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2004 | 8 | 0.220 |
Why?
|
| Peroxidase | 1 | 2004 | 15 | 0.220 |
Why?
|
| Vasculitis | 1 | 2004 | 26 | 0.220 |
Why?
|
| Infant, Premature, Diseases | 1 | 2004 | 26 | 0.220 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2014 | 51 | 0.220 |
Why?
|
| Lung Diseases | 1 | 2004 | 36 | 0.210 |
Why?
|
| Hemorrhage | 1 | 2004 | 73 | 0.210 |
Why?
|
| Kidney Diseases | 1 | 2004 | 68 | 0.210 |
Why?
|
| Adult | 11 | 2018 | 6896 | 0.210 |
Why?
|
| Male | 17 | 2022 | 12400 | 0.200 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2023 | 1 | 0.200 |
Why?
|
| Shellfish Hypersensitivity | 1 | 2022 | 1 | 0.190 |
Why?
|
| Cockroaches | 1 | 2022 | 2 | 0.190 |
Why?
|
| Celiac Disease | 1 | 2002 | 7 | 0.190 |
Why?
|
| Digestive System | 1 | 2002 | 14 | 0.190 |
Why?
|
| Pancreatitis | 1 | 2002 | 20 | 0.180 |
Why?
|
| Crohn Disease | 1 | 2002 | 37 | 0.180 |
Why?
|
| Prospective Studies | 5 | 2023 | 1487 | 0.180 |
Why?
|
| Quality of Life | 2 | 2023 | 559 | 0.180 |
Why?
|
| Diet | 2 | 2021 | 178 | 0.180 |
Why?
|
| Microbiota | 2 | 2018 | 65 | 0.170 |
Why?
|
| Bullying | 1 | 2020 | 2 | 0.170 |
Why?
|
| Chronic Disease | 6 | 2018 | 364 | 0.160 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2013 | 6 | 0.160 |
Why?
|
| Mastocytosis | 1 | 2019 | 1 | 0.160 |
Why?
|
| Poverty | 1 | 2020 | 85 | 0.160 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 157 | 0.150 |
Why?
|
| Parents | 1 | 2020 | 106 | 0.150 |
Why?
|
| Physicians | 1 | 2020 | 104 | 0.150 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 2008 | 6 | 0.140 |
Why?
|
| Prevalence | 4 | 2023 | 375 | 0.140 |
Why?
|
| Nose | 1 | 2018 | 30 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 25 | 0.130 |
Why?
|
| Pollen | 1 | 2016 | 2 | 0.130 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2016 | 3 | 0.130 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2017 | 51 | 0.130 |
Why?
|
| Minority Groups | 1 | 2016 | 67 | 0.120 |
Why?
|
| Middle Aged | 9 | 2018 | 7873 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 71 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 69 | 0.120 |
Why?
|
| Skin Tests | 1 | 2015 | 6 | 0.120 |
Why?
|
| Nasal Polyps | 1 | 2016 | 45 | 0.120 |
Why?
|
| Granulocytes | 1 | 2014 | 15 | 0.110 |
Why?
|
| United States | 4 | 2021 | 1762 | 0.110 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 17 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2014 | 69 | 0.110 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 10 | 0.100 |
Why?
|
| Hospitalization | 1 | 2016 | 285 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 50 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2022 | 1412 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2016 | 534 | 0.100 |
Why?
|
| Odds Ratio | 2 | 2016 | 217 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 240 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 192 | 0.090 |
Why?
|
| Receptors, IgE | 1 | 2009 | 1 | 0.080 |
Why?
|
| Immunoglobulin E | 1 | 2009 | 9 | 0.080 |
Why?
|
| Aged | 5 | 2016 | 7412 | 0.080 |
Why?
|
| Pregnancy | 2 | 2013 | 324 | 0.070 |
Why?
|
| Neutrophils | 1 | 2009 | 89 | 0.070 |
Why?
|
| South Africa | 2 | 2018 | 7 | 0.070 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2008 | 5 | 0.070 |
Why?
|
| Risk Factors | 2 | 2017 | 1966 | 0.070 |
Why?
|
| Cytokines | 1 | 2008 | 202 | 0.070 |
Why?
|
| Health Education | 1 | 2006 | 40 | 0.060 |
Why?
|
| Data Collection | 1 | 2006 | 80 | 0.060 |
Why?
|
| Enterocolitis | 1 | 2006 | 4 | 0.060 |
Why?
|
| Mastocytosis, Systemic | 1 | 2006 | 6 | 0.060 |
Why?
|
| Diarrhea | 1 | 2006 | 31 | 0.060 |
Why?
|
| Illinois | 2 | 2017 | 221 | 0.060 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 8 | 0.060 |
Why?
|
| Young Adult | 3 | 2018 | 1647 | 0.060 |
Why?
|
| Depression | 1 | 2008 | 368 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2004 | 17 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2004 | 58 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2016 | 2976 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2004 | 95 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2004 | 186 | 0.050 |
Why?
|
| Dermatophagoides pteronyssinus | 1 | 2022 | 1 | 0.050 |
Why?
|
| Dust | 1 | 2022 | 2 | 0.050 |
Why?
|
| Pyroglyphidae | 1 | 2022 | 2 | 0.050 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2022 | 2 | 0.050 |
Why?
|
| Gastric Acid | 1 | 2002 | 9 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 795 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2022 | 52 | 0.050 |
Why?
|
| Permeability | 1 | 2002 | 90 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 123 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2002 | 32 | 0.040 |
Why?
|
| Acute Disease | 1 | 2002 | 162 | 0.040 |
Why?
|
| Shellfish | 1 | 2021 | 2 | 0.040 |
Why?
|
| Schools | 1 | 2020 | 36 | 0.040 |
Why?
|
| Food | 1 | 2020 | 30 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 3717 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 350 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 98 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 759 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 56 | 0.040 |
Why?
|
| Biodiversity | 1 | 2018 | 31 | 0.040 |
Why?
|
| Syndrome | 1 | 2016 | 66 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 370 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 63 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 102 | 0.030 |
Why?
|
| Aspirin | 1 | 2016 | 48 | 0.030 |
Why?
|
| Animals | 1 | 2022 | 3255 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 255 | 0.030 |
Why?
|
| Exhalation | 1 | 2014 | 3 | 0.030 |
Why?
|
| Spirometry | 1 | 2014 | 9 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2014 | 58 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 30 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 72 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 227 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2013 | 12 | 0.030 |
Why?
|
| Vincristine | 1 | 2013 | 23 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2013 | 10 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 26 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2013 | 44 | 0.030 |
Why?
|
| Rituximab | 1 | 2013 | 38 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2013 | 49 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 481 | 0.020 |
Why?
|
| Prednisone | 1 | 2013 | 64 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2013 | 57 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 231 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 377 | 0.020 |
Why?
|
| Basophils | 1 | 2009 | 7 | 0.020 |
Why?
|
| Superoxides | 1 | 2009 | 22 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 122 | 0.020 |
Why?
|
| Ranitidine | 1 | 2006 | 3 | 0.020 |
Why?
|
| Cetirizine | 1 | 2006 | 3 | 0.020 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2006 | 3 | 0.020 |
Why?
|
| Tryptases | 1 | 2006 | 5 | 0.020 |
Why?
|
| Duodenum | 1 | 2006 | 5 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2006 | 14 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 71 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 162 | 0.010 |
Why?
|
| Colon | 1 | 2006 | 110 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 2934 | 0.010 |
Why?
|